Beliefs and preferences regarding biological treatments for severe asthma

Autor: Andras Bikov, Ipek Kivilcim Oğuzülgen, Ilaria Baiardini, Marco Contoli, Alexander Emelyanov, Omar Fassio, Juan Carlos Ivancevich, Igor Kaidashev, Krzysztof Kowal, Marina Labor, Lies Lahousse, Stefan Mihaicuta, Silviya Novakova, Alicia Padilla Galo, Alexander Simidchiev, Angelica Tiotiu, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Nelson Rosario, Pierachille Santus, Fulvio Braido, Carmen Ardelean, Hector Badellino, Ariel Blua, Antonio Castillo, E. Carpagnano Giovanna, J. Chong-Neto Herberto, F. Daniel Colodenco, Dario Md Colombaro, Jaime Correia-De-Sousa, Fabiano Di Marco, Kunio Dobashi, Rocio Garcia, René Maximiliano Gomez, Olecsandr Gopko, Guillermo Guidos, Martina Hajduk, Joanna Hermanowicz-Salamon, Enrico Heffler, Bulent Karadag, Ali F. Kalyoncu, Metin Keren, Lykorguos Kolilekas, Marcelina Kocwin, Borislava Krusheva, Désirée Larenas Linnemann, Irine Litovchenko, A. Marcipar, L.E. Meza, D. Nedeva, P. Novakova, D. Plavec, S. Popović-Grle, F. Puggioni, L. Pur Oziygit, N. Rodrigez, D. Ryan, I. Ruzsics, N. Scichilone, F. Serpa, P. Steiropoulos, P. Solidoro, M. Turkalj, T. Umanets, C.F. Victorio, J.M. Zubeldia, V. Yachnyk, M. Zitt

Publikováno v: World Allergy Organization Journal, Vol 13, Iss 7, Pp 100441- (2020)

Background: Severe asthma is a serious condition with a significant burden on patients' morbidity, mortality, and quality of life. Some biological therapies targeting the IgE and interleukin-5 (IL5) mediated pathways are now available. Due to the lac

Externí odkaz: https://doaj.org/article/f09379c335d94a92a335642970992c00